
TY  - JOUR
TI  - HUMORAL ASPECTS OF AUTOIMMUNE DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_13.x
DO  - doi:10.1111/j.1479-8077.2006.00199_13.x
SP  - A79
EP  - A80
PY  - 2006
ER  - 

TY  - JOUR
TI  - OTHERS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_21.x
DO  - doi:10.1111/j.1479-8077.2006.00199_21.x
SP  - A142
EP  - A159
PY  - 2006
ER  - 

TY  - JOUR
TI  - SYSTEMIC LUPUS ERYTHEMATOSUS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_30.x
DO  - doi:10.1111/j.1479-8077.2006.00199_30.x
SP  - A253
EP  - A274
PY  - 2006
ER  - 

TY  - JOUR
TI  - VASCULITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_31.x
DO  - doi:10.1111/j.1479-8077.2006.00199_31.x
SP  - A274
EP  - A278
PY  - 2006
ER  - 

TY  - JOUR
TI  - MYOPATHIES AND SOFT TISSUE RHEUMATISM INCLUDING FIBROMYALGIA
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_17.x
DO  - doi:10.1111/j.1479-8077.2006.00199_17.x
SP  - A99
EP  - A101
PY  - 2006
ER  - 

TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODEL
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_25.x
DO  - doi:10.1111/j.1479-8077.2006.00199_25.x
SP  - A211
EP  - A225
PY  - 2006
ER  - 

TY  - JOUR
TI  - GLIA Bilbao 2015: Abstracts Oral Presentations, Posters, Indexes
JO  - Glia
JA  - Glia
VL  - 63
IS  - S1
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.22870
DO  - doi:10.1002/glia.22870
SP  - E76
EP  - E469
PY  - 2015
ER  - 

TY  - JOUR
TI  - CELL RECEPTOR-LIGAND INTERACTION, SIGNALING AND ACTIVATION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_6.x
DO  - doi:10.1111/j.1479-8077.2006.00199_6.x
SP  - A39
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
TI  - CYTOKINES AND INFLAMMATORY MEDIATORS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_7.x
DO  - doi:10.1111/j.1479-8077.2006.00199_7.x
SP  - A39
EP  - A45
PY  - 2006
ER  - 

TY  - JOUR
AU  - Liu, Yijun
AU  - Ma, Teng
TI  - Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application
JO  - Biotechnology Progress
JA  - Biotechnol Progress
VL  - 31
IS  - 2
SN  - 8756-7938
UR  - https://doi.org/10.1002/btpr.2034
DO  - doi:10.1002/btpr.2034
SP  - 468
EP  - 481
KW  - mesenchymal stem or stromal cells
KW  - energy metabolism
KW  - hypoxia
KW  - glucose
KW  - expansion
KW  - differentiation
KW  - apoptosis
KW  - transplantation
PY  - 2015
AB  - Human mesenchymal or stromal cells (hMSCs) isolated from various adult tissues are primary candidates in cell therapy and tissue regeneration. Despite promising results in preclinical studies, robust therapeutic responses to MSC treatment have not been reproducibly demonstrated in clinical trials. In the translation of MSC-based therapy to clinical application, studies of MSC metabolism have significant implication in optimizing bioprocessing conditions to obtain therapeutically competent hMSC population for clinical application. In addition, understanding the contribution of metabolic cues in directing hMSC fate also provides avenues to potentiate their therapeutic effects by modulating their metabolic properties. This review focuses on MSC metabolism and discusses their unique metabolic features in the context of common metabolic properties shared by stem cells. Recent advances in the fundamental understanding of MSC metabolic characteristics in relation to their in vivo origin and metabolic regulation during proliferation, lineage-specific differentiation, and exposure to in vivo ischemic conditions are summarized. Metabolic strategies in directing MSC fate to enhance their therapeutic potential in tissue engineering and regenerative medicine are discussed. ? 2014 American Institute of Chemical Engineers Biotechnol. Prog., 31:468?481, 2015
ER  - 

TY  - JOUR
AU  - Brady, Angela F.
AU  - Demirdas, Serwet
AU  - Fournel-Gigleux, Sylvie
AU  - Ghali, Neeti
AU  - Giunta, Cecilia
AU  - Kapferer-Seebacher, Ines
AU  - Kosho, Tomoki
AU  - Mendoza-Londono, Roberto
AU  - Pope, Michael F.
AU  - Rohrbach, Marianne
AU  - Van Damme, Tim
AU  - Vandersteen, Anthony
AU  - van Mourik, Caroline
AU  - Voermans, Nicol
AU  - Zschocke, Johannes
AU  - Malfait, Fransiska
TI  - The Ehlers–Danlos syndromes, rare types
JO  - American Journal of Medical Genetics Part C: Seminars in Medical Genetics
JA  - Am. J. Med. Genet.
VL  - 175
IS  - 1
SN  - 1552-4868
UR  - https://doi.org/10.1002/ajmg.c.31550
DO  - doi:10.1002/ajmg.c.31550
SP  - 70
EP  - 115
KW  - Ehlers–Danlos syndromes
KW  - heritable connective tissue disorders
KW  - collagen
PY  - 2017
AB  - The Ehlers?Danlos syndromes comprise a clinically and genetically heterogeneous group of heritable connective tissue disorders, which are characterized by joint hypermobility, skin hyperextensibility, and tissue friability. In the Villefranche Nosology, six subtypes were recognized: The classical, hypermobile, vascular, kyphoscoliotic, arthrochalasis, and dermatosparaxis subtypes of EDS. Except for the hypermobile subtype, defects had been identified in fibrillar collagens or in collagen-modifying enzymes. Since 1997, a whole spectrum of novel, clinically overlapping, rare EDS-variants have been delineated and genetic defects have been identified in an array of other extracellular matrix genes. Advances in molecular testing have made it possible to now identify the causative mutation for many patients presenting these phenotypes. The aim of this literature review is to summarize the current knowledge on the rare EDS subtypes and highlight areas for future research. ? 2017 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - GENOMICS, GENETIC BASIS OF DISEASE AND HLA/T CELL RECOGNITION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_11.x
DO  - doi:10.1111/j.1479-8077.2006.00199_11.x
SP  - A66
EP  - A68
PY  - 2006
ER  - 

TY  - JOUR
TI  - INFECTION-RELATED RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_14.x
DO  - doi:10.1111/j.1479-8077.2006.00199_14.x
SP  - A80
EP  - A83
PY  - 2006
ER  - 

TY  - JOUR
TI  - MISCELLANEOUS RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_16.x
DO  - doi:10.1111/j.1479-8077.2006.00199_16.x
SP  - A90
EP  - A99
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOPOROSIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_20.x
DO  - doi:10.1111/j.1479-8077.2006.00199_20.x
SP  - A125
EP  - A142
PY  - 2006
ER  - 

TY  - JOUR
TI  - SPONDYLOARTHROPATHIES INCLUDING PSORIATIC ARTHRITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_28.x
DO  - doi:10.1111/j.1479-8077.2006.00199_28.x
SP  - A234
EP  - A247
PY  - 2006
ER  - 

TY  - JOUR
TI  - BACK PAIN
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_3.x
DO  - doi:10.1111/j.1479-8077.2006.00199_3.x
SP  - A26
EP  - A31
PY  - 2006
ER  - 

TY  - JOUR
TI  - BONE DISEASES OTHER THAN OSTEOPOROSIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_4.x
DO  - doi:10.1111/j.1479-8077.2006.00199_4.x
SP  - A31
EP  - A33
PY  - 2006
ER  - 

TY  - JOUR
TI  - METABOLIC AND CRYSTAL ARTHROPATHIES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_15.x
DO  - doi:10.1111/j.1479-8077.2006.00199_15.x
SP  - A83
EP  - A90
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOARTHRITIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_19.x
DO  - doi:10.1111/j.1479-8077.2006.00199_19.x
SP  - A108
EP  - A125
PY  - 2006
ER  - 
